Calavo Q3 net sales $178.8M; adjusted EPS $0.57; FDA detention costs $4.2M

CALAVO GROWERS INC

2025-Q3 EPS reported $0.89 revenue$523,753,000

Total net sales $178.8M (down <1% YoY); Fresh segment $155.9M (-5%), Prepared $22.9M (+40%).
Gross profit $18.2M (-9%); includes ~$4.2M one-time FDA detention costs on Mexican avocado imports.
Net income from continuing ops $4.7M ($0.26 diluted) vs $5.4M; adjusted net income $10.2M ($0.57) vs $10.0M ($0.56).
Prepared segment gross profit $5.8M (+201%); Fresh segment gross profit $12.4M (-32%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.